Allianz Asset Management Gmb H Apellis Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

$72.3 Billion
Q4 2024

A detailed history of Allianz Asset Management Gmb H transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 18,800 shares of APLS stock, worth $456,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,800

Previous 7,400 154.05%

Holding current value

$456,276

Previous $213,000 181.22%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$26.18 - $35.42 $298,452 - $403,788	11,400 Added 154.05%	18,800 $599,000
Q3 2024 Nov 12, 2024	SELL	$28.84 - $41.15 $178,808 - $255,130	-6,200 Reduced 45.59%	7,400 $213,000
Q3 2023 Nov 13, 2023	SELL	$23.65 - $89.22 $212,850 - $802,980	-9,000 Reduced 39.82%	13,600 $517,000
Q2 2023 Aug 11, 2023	BUY	$76.68 - $93.31 $352,728 - $429,226	4,600 Added 25.56%	22,600 $2.06 Million
Q1 2023 May 11, 2023	BUY	$46.59 - $66.96 $838,620 - $1.21 Million	18,000 New	18,000 $1.19 Million
Q3 2022 Nov 08, 2022	SELL	$44.76 - $69.66 $1.98 Million - $3.07 Million	-44,140 Reduced 80.05%	11,000 $751,000
Q2 2022 Aug 12, 2022	BUY	$35.07 - $59.21 $792,231 - $1.34 Million	22,590 Added 69.4%	55,140 $2.49 Million
Q1 2022 May 13, 2022	BUY	$35.46 - $54.12 $113,472 - $173,184	3,200 Added 10.9%	32,550 $1.65 Million
Q4 2021 Feb 11, 2022	BUY	$30.74 - $49.16 $902,219 - $1.44 Million	29,350 New	29,350 $1.39 Million
Q3 2021 Nov 10, 2021	SELL	$31.4 - $69.84 $823,936 - $1.83 Million	-26,240 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$40.9 - $64.9 $856,446 - $1.36 Million	20,940 Added 395.09%	26,240 $1.66 Million
Q4 2020 Feb 16, 2021	SELL	$30.79 - $57.2 $579,467 - $1.08 Million	-18,820 Reduced 78.03%	5,300 $303,000
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $54,420 - $70,732	-2,102 Reduced 8.02%	24,120 $728,000
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $47,120 - $73,131	-1,900 Reduced 6.76%	26,222 $857,000
Q1 2020 May 14, 2020	SELL	$17.91 - $44.33 $44,452 - $110,027	-2,482 Reduced 8.11%	28,122 $753,000
Q4 2019 Feb 13, 2020	BUY	$22.1 - $30.8 $676,348 - $942,603	30,604 New	30,604 $937,000

Others Institutions Holding APLS

# of Institutions

300

Shares Held

111M

Call Options Held

2.63M

Put Options Held

845K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.67B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Allianz Asset Management Gmb H with notifications on news.

Account

Allianz Asset Management Gmb H Apellis Pharmaceuticals, Inc. Transaction History